163 related articles for article (PubMed ID: 28854286)
1. Therapeutic time window for conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice.
Zeynalov E; Jones SM; Elliott JP
PLoS One; 2017; 12(8):e0183985. PubMed ID: 28854286
[TBL] [Abstract][Full Text] [Related]
2. Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.
Zeynalov E; Jones SM; Seo JW; Snell LD; Elliott JP
PLoS One; 2015; 10(8):e0136121. PubMed ID: 26275173
[TBL] [Abstract][Full Text] [Related]
3. Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema.
Zeynalov E; Jones SM; Elliott JP
J Vis Exp; 2016 Sep; (115):. PubMed ID: 27684044
[TBL] [Abstract][Full Text] [Related]
4. Conivaptan, a Selective Arginine Vasopressin V1a and V2 Receptor Antagonist Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4.
Nakayama S; Amiry-Moghaddam M; Ottersen OP; Bhardwaj A
Neurocrit Care; 2016 Apr; 24(2):273-82. PubMed ID: 26732270
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Clinically Relevant Hypertonic Saline and Conivaptan Administration on Ischemic Stroke.
Decker D; Collier L; Lau T; Olivera R; Roma G; Leonardo C; Seifert H; Rowe D; Pennypacker KR
Acta Neurochir Suppl; 2016; 121():243-50. PubMed ID: 26463956
[TBL] [Abstract][Full Text] [Related]
6. Cerebralcare Granule® attenuates blood-brain barrier disruption after middle cerebral artery occlusion in rats.
Huang P; Zhou CM; Qin-Hu ; Liu YY; Hu BH; Chang X; Zhao XR; Xu XS; Li Q; Wei XH; Mao XW; Wang CS; Fan JY; Han JY
Exp Neurol; 2012 Oct; 237(2):453-63. PubMed ID: 22868201
[TBL] [Abstract][Full Text] [Related]
7. Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.
Liu X; Nakayama S; Amiry-Moghaddam M; Ottersen OP; Bhardwaj A
Neurocrit Care; 2010 Feb; 12(1):124-31. PubMed ID: 19806476
[TBL] [Abstract][Full Text] [Related]
8. Effect of arginine vasopressin on the cortex edema in the ischemic stroke of Mongolian gerbils.
Zhao XY; Wu CF; Yang J; Gao Y; Sun FJ; Wang DX; Wang CH; Lin BC
Neuropeptides; 2015 Jun; 51():55-62. PubMed ID: 25843346
[TBL] [Abstract][Full Text] [Related]
9. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
Vakili A; Hosseinzadeh F; Sadogh T
Brain Res; 2007 Sep; 1170():97-102. PubMed ID: 17698046
[TBL] [Abstract][Full Text] [Related]
10. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
11. Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature.
Hedna VS; Bidari S; Gubernick D; Ansari S; Satriotomo I; Khan AA; Qureshi AI
BMC Neurol; 2014 Nov; 14():213. PubMed ID: 25403760
[TBL] [Abstract][Full Text] [Related]
12. Intra-artery infusion of recombinant human erythropoietin reduces blood-brain barrier disruption in rats following cerebral ischemia and reperfusion.
Wang R; Wu X; Liang J; Qi Z; Liu X; Min L; Ji X; Luo Y; Zhao H
Int J Neurosci; 2015; 125(9):693-702. PubMed ID: 25226558
[TBL] [Abstract][Full Text] [Related]
13. YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice.
Cao G; Ye X; Xu Y; Yin M; Chen H; Kou J; Yu B
Drug Des Devel Ther; 2016; 10():315-25. PubMed ID: 26834461
[TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke.
Kahles T; Luedike P; Endres M; Galla HJ; Steinmetz H; Busse R; Neumann-Haefelin T; Brandes RP
Stroke; 2007 Nov; 38(11):3000-6. PubMed ID: 17916764
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin gene-related peptide prevents blood-brain barrier injury and brain edema induced by focal cerebral ischemia reperfusion.
Liu Z; Liu Q; Cai H; Xu C; Liu G; Li Z
Regul Pept; 2011 Nov; 171(1-3):19-25. PubMed ID: 21718723
[TBL] [Abstract][Full Text] [Related]
16. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia.
Vakili A; Kataoka H; Plesnila N
J Cereb Blood Flow Metab; 2005 Aug; 25(8):1012-9. PubMed ID: 15744246
[TBL] [Abstract][Full Text] [Related]
17. Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs.
Zhang HT; Zhang P; Gao Y; Li CL; Wang HJ; Chen LC; Feng Y; Li RY; Li YL; Jiang CL
Mol Med Rep; 2017 Jan; 15(1):57-64. PubMed ID: 27909732
[TBL] [Abstract][Full Text] [Related]
18. The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood-brain-barrier damage, inflammation and thrombosis.
Kraft P; Schwarz T; Göb E; Heydenreich N; Brede M; Meuth SG; Kleinschnitz C
Exp Neurol; 2013 Sep; 247():80-90. PubMed ID: 23570902
[TBL] [Abstract][Full Text] [Related]
19. Orosomucoid1: Involved in vascular endothelial growth factor-induced blood-brain barrier leakage after ischemic stroke in mouse.
Wu L; Jiang Y; Zhu J; Wen Z; Xu X; Xu X; Xie Y; Yang L; Xu L; Lan W; Xu G; Liu X
Brain Res Bull; 2014 Oct; 109():88-98. PubMed ID: 25264156
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.
Ludewig P; Sedlacik J; Gelderblom M; Bernreuther C; Korkusuz Y; Wagener C; Gerloff C; Fiehler J; Magnus T; Horst AK
Circ Res; 2013 Sep; 113(8):1013-22. PubMed ID: 23780386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
